Both in Pharmaceuticals
Savara vs Latigo Biotherapeutics
Over the past year SVRA returned −10.4% and LTGO returned −34.2%; their daily moves had a correlation of 0.33.
SVRA −10.4% LTGO −34.2%Growth of $1, one year, split-adjusted
| Metric | SVRA | LTGO |
|---|---|---|
| Price | $4.75 | $14.57 |
| Market cap | $975.9M | $966.0M |
| Today | +0.42% | +7.85% |
| 1 month | −0.6% | −12.4% |
| 6 months | −9.5% | — |
| Year to date | −21.2% | — |
| 1 year | +14.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | — |
| Short % of float | 20.1% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).